In Section A, contributors will receive unique doses and schedules of oral ABBV-744 pill to recognize safe dosing regimen. More participants is going to be enrolled at the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will be offered as "include-on" therapy. In Section https://alexisujvfq.slypage.com/32497046/abbv-744-clinical-trial-phase-2-data-things-to-know-before-you-buy